Eli Lilly has reported that its interleukin-13 (IL-13) inhibitor Ebglyss (lebrikizumab-lbkz) showed sustained skin clearance ...
Zacks Investment Research on MSN
What's the Driving Force Behind Eli Lilly's Recent Acquisition Spree?
Eli Lilly LLY has been on an acquisition spree since the beginning of this year to bolster its pipeline, which should drive ...
The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and spawning a ...
Eli Lilly is promoting its Alzheimer’s medication Kisunla with a national ad campaign centered on hope for treating the disease as well as the importance of early detection and screening. Lilly’s ...
The Institute for Clinical and Economic Review (ICER) has updated its assessment of the value of Novo Nordisk’s (NOV: N) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback